Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenalytix Plc Regulatory News (RENX)

Share Price Information for Renalytix Plc (RENX)

Share Price is delayed by 15 minutes
Get Live Data
1.90    0.00 (0.00%)
Bid:
1.80
Ask:
2.00
Spread: 0.20 (11.111%)
Market Cap: £8.30m
RENX Live PriceLast checked at - London Stock Exchange

Intraday Renalytix Plc Share Chart

Director/PDMR Shareholding - Replacement

22 Jun 2021 13:25

RNS Number : 7366C
Renalytix AI PLC
22 June 2021
 

The following amendment(s) has been made to the ' Director/PDMR Dealing' announcement released on 22 June 2021 at 10:57 under RNS No 7062C.

 

The price of 113.5 pence per share was incorrect and has been amended to 1135 pence per share.

The Company was also informed of the sale 'yesterday'.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Renalytix AI plc 

 

("Renalytix" or the "Company")

 

Director/PDMR Dealing

 

The Company was informed that yesterday, Christopher Mills, a non-executive director and interim Chairman, completed the sale of 17,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 1135 pence per share.

 

Following completion of the sale, Christopher Mills is interested in 9,180,501 Ordinary Shares representing 12.74% of the current issued share capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 

Harwood Capital LLP and Harwood Capital Management (Gibraltar) Limited as investment manager to North Atlantic Smaller Companies Investment Trust plc and Oryx

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills, non-exec director and Interim Chair of the issuer and director of NASCIT and Oryx International Growth Fund Ltd

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Renalytix AI plc

b)

 

LEI

 

 

213800NTOH3FK3WER551

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.0025 each

Identification code

GB00BYWL4Y04

 

 

b)

 

Nature of the transaction

 

 

Sale of shares

c)

Currency

GBP

d)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

Volume(s)

 

 

£11.352941

17,000

 

 

 

 

 

e)

 

Aggregated information

- Aggregated volume

17,000

- Price

£192,999.99

f)

 

Date of the transaction

 

 

18 June 2021

g)

 

Place of the transaction

 

 

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGZVZZFGMZM
Date   Source Headline
4th Nov 20245:42 pmRNSHolding(s) in Company
31st Oct 20243:10 pmRNSDirectorate Change
31st Oct 20242:10 pmRNSResult of General Meeting
11th Oct 20244:55 pmRNSPosting of Circular & Notice of GM
11th Oct 20247:02 amRNSDirector/PDMR Shareholding
11th Oct 20247:01 amRNSHolding(s) in Company
11th Oct 20247:00 amRNSHolding(s) in Company
9th Oct 20244:40 pmRNSHolding(s) in Company
8th Oct 20241:55 pmRNSAdmission of Shares & Total Voting Rights
8th Oct 20247:00 amRNSCommencement of trading on OTCQB in the US
1st Oct 202412:02 pmRNSResult of Placing and Subscription
1st Oct 20247:00 amRNSAudited US GAAP financial results
30th Sep 20245:42 pmRNSPlacing and Subscription
30th Sep 20245:41 pmRNSRe. Results for the fiscal year ended 30 June '24
30th Aug 20247:00 amRNSChange of Adviser
30th Aug 20247:00 amRNSTotal Voting Rights
27th Aug 20249:30 amRNSNasdaq Grants Listing Extension
21st Aug 20247:00 amRNSAppointment of Joint Corporate Broker
20th Aug 20247:00 amRNSTermination of Formal Sale Process
16th Aug 20242:08 pmRNSForm 8.3 - RENALYTIX PLC
15th Aug 202412:37 pmRNSForm 8.3 - RENALYTIX PLC
14th Aug 20249:47 amGNWForm 8.5 (EPT/RI)-Renalytix Plc
13th Aug 20243:08 pmRNSForm 8.3 - RENALYTIX PLC
7th Aug 20249:09 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
6th Aug 20249:42 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
5th Aug 20249:36 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
2nd Aug 202410:21 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
1st Aug 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
31st Jul 20249:24 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
30th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
30th Jul 20249:46 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
30th Jul 20247:00 amRNSTotal Voting Rights
18th Jul 20247:57 amGNWForm 8.5 (EPT/RI)-Renalytix Plc
16th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
16th Jul 20247:46 amGNWForm 8.5 (EPT/RI)-Renalytix plc
15th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
15th Jul 20247:00 amRNSIssue of Shares and Rule 2.9 Announcement
12th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
12th Jul 20249:05 amGNWForm 8.5 (EPT/RI) - Renalytix Plc
11th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
11th Jul 20247:00 amRNSSteno Diabetes Center (Copenhagen) Collaboration
10th Jul 20243:26 pmRNSHolding(s) in Company
10th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
9th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
8th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
5th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
4th Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc
3rd Jul 202410:01 amRNSForm 8.5 (EPT/RI) - Renalytix plc - Amendment
2nd Jul 202412:00 pmRNSForm 8.5 (EPT/RI) - Renalytix plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.